Skip to main content
. 2013 Mar 7;121(18):3573–3577. doi: 10.1182/blood-2013-01-476614

Table 3.

Poisson regression evaluating the influence of any antifungal prophylaxis (N = 722) or antimold prophylaxis (N = 62)

Infection N Any antifungal prophylaxis
Any antimold prophylaxis
IRR (95% CI) P Adjusted IRR (95% CI) Adjusted P* IRR P Adjusted IRR (95% CI) Adjusted P*
Any sterile-site bacterial infection 612 0.96 (0.84-1.09) .514 0.94 (0.82-1.07) .371 0.88 (0.71-1.09) .244 0.94 (0.75-1.18) .584
Gram-positive sterile-site bacterial infection 512 0.85 (0.73-0.99) .041 0.82 (0.70-0.97) .021 0.70 (0.52-0.95) .023 0.70 (0.50-0.98) .036
Gram-negative sterile-site bacterial infection 78 1.02 (0.59-1.79) .932 1.21 (0.64-2.31) .560 1.36 (0.63-2.95) .433 1.46 (0.63-3.39) .379
C difficile infection 123 1.28 (0.83-1.98) .263 1.24 (0.80-1.94) .339 0.38 (0.14-1.03) .056 0.40 (0.15-1.09) .074
Sterile-site fungal infection 49 1.06 (0.52-2.18) .865 1.62 (0.69-3.83) .271 1.59 (0.63-4.01) .321 1.62 (0.58-4.56) .361
*

Analysis adjusted for age, race, and weight group.